MYOLYN Company Profile

Background

Mission and Vision

MYOLYN is dedicated to enhancing health and human performance by empowering individuals to move. The company focuses on developing innovative medical devices that restore mobility, health, and independence to people living with paralysis.

Primary Area of Focus

Specializing in Functional Electrical Stimulation (FES) technology, MYOLYN designs, manufactures, and markets rehabilitation and therapy devices for individuals with muscle weakness or paralysis. Their flagship product, the MyoCycle, enables therapeutic exercise for those affected by neurological disorders such as spinal cord injury, stroke, multiple sclerosis, brain injury, and others.

Industry Significance

By integrating advanced robotics and automation into FES therapy, MYOLYN has made significant strides in transitioning rehabilitation from clinical settings to home environments, thereby increasing accessibility and convenience for patients.

Key Strategic Focus

Core Objectives

Develop and commercialize affordable, easy-to-use FES therapy systems.

Expand the availability of home-based rehabilitation solutions.

Enhance patient outcomes through innovative technology.

Areas of Specialization

FES cycling therapy systems for home and clinical use.

Rehabilitation devices targeting muscle re-education and prevention of muscle atrophy.

Key Technologies Utilized

Proprietary FES algorithms for muscle stimulation.

Automated calibration and control systems for personalized therapy.

Primary Markets Targeted

Individuals with neurological disorders resulting in lower body weakness or paralysis.

Rehabilitation clinics and hospitals seeking advanced therapy solutions.

Financials and Funding

Funding History

In September 2015, MYOLYN secured funding from the Florida Institute for the Commercialization of Public Research to support the commercialization of its rehabilitation technology.

Utilization of Capital

The funds have been directed towards product development, regulatory approvals, and expanding market reach.

Pipeline Development

Key Products

MyoCycle Home: Designed for home use, enabling individuals to perform therapeutic cycling exercises independently.

MyoCycle Pro: Intended for clinical settings, offering advanced features for healthcare professionals.

Development Milestones

April 2017: FDA 510(k) clearance for MyoCycle Home and MyoCycle Pro.

April 2022: FDA clearance for four new MyoCycle models, introducing additional stimulation channels and muscle group targeting options.

Technological Platform and Innovation

Proprietary Technologies

Patent-pending FES algorithms that automate therapy parameter optimization, enhancing ease of use.

Significant Scientific Methods

Integration of robotics and control theory to develop FES cycling systems that adapt to individual patient needs.

Leadership Team

Alan J. Hamlet, PhD: Co-founder and Chief Executive Officer. Holds a PhD in Mechanical Engineering from the University of Florida, with experience in designing space flight critical mechanical systems at SpaceX.

Matthew Bellman, PhD: Co-founder and Chief Technology Officer. Specializes in the control of human muscle using FES, with a PhD dissertation focused on FES-induced cycling.

Competitor Profile

Market Insights and Dynamics

The rehabilitation device market is experiencing growth due to increasing incidences of neurological disorders and a rising demand for home-based therapy solutions.

Competitor Analysis

RehaStim: Offers FES devices for clinical and home use, focusing on muscle re-education and atrophy prevention.

Restorative Therapies: Provides integrated FES systems targeting neurological rehabilitation, with a range of products for different patient needs.

Strategic Collaborations and Partnerships

Lifeward Ltd.: In March 2025, MYOLYN expanded its partnership with Lifeward to enhance patient access to the MyoCycle FES Cycling Therapy System for home use.

YMCA: Collaborated to provide therapeutic exercise to people with disabilities by integrating MyoCycle Pro systems into community fitness programs.

Operational Insights

Strategic Considerations

Emphasis on user-friendly design to facilitate adoption in home settings.

Focus on affordability to increase accessibility for a broader patient population.

Competitive Advantages

Proprietary technology that simplifies FES therapy setup and use.

Strong partnerships enhancing distribution and patient reach.

Strategic Opportunities and Future Directions

Strategic Roadmap

Continue innovation in FES technology to address a wider range of neurological conditions.

Expand global distribution channels to reach underserved markets.

Opportunities for Expansion

Development of new therapy devices targeting upper body rehabilitation.

Integration of data analytics to personalize therapy and track patient progress.

Positioning for Future Objectives

Leveraging technological expertise and strategic partnerships, MYOLYN is well-positioned to lead advancements in home-based rehabilitation solutions, improving patient outcomes and quality of life.